Clinical trials
Phase 2 Leukemia, B-Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2007 | 3 |
| 2010 | 3 |
| 2012 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Center for International Blood and Marrow Transplant Research | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Brown University | 1 |
| Cylene Pharmaceuticals | 1 |
| Etan Orgel | 1 |
| GlaxoSmithKline | 1 |
| MedImmune LLC | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Novartis Pharmaceuticals | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, B-Cell | 20 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 13 |
| Leukemia | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
| Leukemia, Lymphoid | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Neoplasms | 5 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma | 4 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.